Skip to main content
SpringerLink
Log in

Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E, Furlanut M (2012) Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J Antimicrob Chemother 67(8):2034–2042. https://doi.org/10.1093/jac/dks153

    Article  PubMed  CAS  Google Scholar 

  2. Pea F, Viale P, Cojutti P, Furlanut M (2012) Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach. Antimicrob Agents Chemother 56(12):6343–6348. https://doi.org/10.1128/AAC.01291-12

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Carrie C, Petit L, D'Houdain N, Sauvage N, Cottenceau V, Lafitte M, Foumenteze C, Hisz Q, Menu D, Legeron R, Breilh D, Sztark F (2017) Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of beta-lactams administered by continuous infusion. a prospective observational study. Int J Antimicrob Agents doi https://doi.org/10.1016/j.ijantimicag.2017.11.013

  4. MacGowan AP (2003) Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections. J Antimicrob Chemother 51(Suppl 2):ii17–ii25. https://doi.org/10.1093/jac/dkg248

    Article  PubMed  CAS  Google Scholar 

  5. Kees MG, Minichmayr IK, Moritz S, Beck S, Wicha SG, Kees F, Kloft C, Steinke T (2016) Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients. J Clin Pharmacol 56(3):307–315. https://doi.org/10.1002/jcph.600

    Article  PubMed  CAS  Google Scholar 

  6. Cojutti P, Sartor A, Righi E, Scarparo C, Bassetti M, Pea F (2017) Population pharmacokinetics of high-dose continuous-infusion meropenem and considerations for use in the treatment of infections due to KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 61(10):e00794–e00717. https://doi.org/10.1128/AAC.00794-17

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Neely MN, van Guilder MG, Yamada WM, Schumitzky A, Jelliffe RW (2012) Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Ther Drug Monit 34(4):467–476. https://doi.org/10.1097/FTD.0b013e31825c4ba6

    Article  PubMed  PubMed Central  Google Scholar 

  8. May CC, Arora S, Parli SE, Fraser JF, Bastin MT, Cook AM (2015) Augmented renal clearance in patients with subarachnoid hemorrhage. Neurocrit Care 23(3):374–379. https://doi.org/10.1007/s12028-015-0127-8

    Article  PubMed  CAS  Google Scholar 

  9. Carrie C, Bentejac M, Cottenceau V, Masson F, Petit L, Cochard JF, Sztark F (2018) Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: a preliminary study. Anaesth Crit Care Pain Med 37(1):35–41. https://doi.org/10.1016/j.accpm.2017.06.006

    Article  PubMed  Google Scholar 

  10. Tang Y, Kong L, Wu C, Zhang X, Lu G, Wu X (2017) Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention. Eur J Clin Pharmacol 73(7):919–921. https://doi.org/10.1007/s00228-017-2239-x

    Article  PubMed  Google Scholar 

Download references

Transparency declaration

W. H. holds or has recently held research grants with F2G, AiCuris, Astellas Pharma, Spero Therapeutics, Matinas Biosciences, Antabio, Amplyx, Allecra, Auspherix and Pfizer and he holds awards from the National Institutes of Health, Medical Research Council, National Institute of Health Research, FDA and the European Commission (FP7 and IMI). W. H. acted as a consultant for F2G, Amplyx, Ausperix, Spero Therapeutics, Medicines Company, Gilead and Basilea in the past 3 years, and he is an Ordinary Council Member for the British Society of Antimicrobial Chemotherapy. F.P. acted as consultants for, and have been on the speakers’ bureau of Angelini, Basilea, Gilead, MSD, Nordic Pharma and Pfizer in the previous 3 years. P.G.C., C.B and A.D.M. had no financial relationships with any organizations that might have an interest in the submitted work.

Author information

Authors and Affiliations

  1. Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital of Udine, Azienda Sanitaria Universitaria Integrata di Udine, P.le S. Maria della Misericordia 3, 33100, Udine, Italy

    Pier Giorgio Cojutti & Federico Pea

  2. Department of Medicine, University of Udine, Udine, Italy

    Pier Giorgio Cojutti & Federico Pea

  3. Department of Anaesthesia and Intensive Care, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy

    Cristina Barbarino & Amato De Monte

  4. Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK

    William Hope

Authors
  1. Pier Giorgio Cojutti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Barbarino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amato De Monte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William Hope
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Federico Pea
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Federico Pea.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cojutti, P.G., Barbarino, C., De Monte, A. et al. Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance. Eur J Clin Pharmacol 74, 1091–1092 (2018). https://doi.org/10.1007/s00228-018-2465-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-2465-x

Search

Navigation